Evidence map›Paper›PMID 30415470›Full record

ReviewPathology oncology research : POR2019

WWP2 Is One Promising Novel Oncogene.

Rui Zhang, Jianwu Zhang, Wei Luo, Zhuang Luo, Shaoqing Shi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pathology oncology research : POR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. The Role of HECT-Type E3 Ligase in the Development of Cardiac Disease.International journal of molecular sciences · 2021
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Rui ZhangDepartment of Thoracic Surgery, The Seventh People's Hospital of Chengdu, Chengdu, Sichuan, 640021, People's Republic of China.
Jianwu ZhangSchool of Pharmacy, North Sichuan Medical College, Nanchong, Sichuan, 637100, People's Republic of China.
Wei LuoDepartment of Respiratory Medicine, The People's Hospital of Leshan, Leshan, Sichuan, 640000, People's Republic of China.
Zhuang LuoDepartment of Pumnary and Critical Care Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, People's Republic of China. sky4511@126.com.
Shaoqing ShiDepartment of Pumnary and Critical Care Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, People's Republic of China. sqs621@yeah.net.ORCID http://orcid.org/0000-0002-1260-3963
Kunming Medical University · CNNorth Sichuan Medical University · CNPeople's Hospital of Bishan District · CNSeventh People's Hospital of Shanghai · CN

Funding

100 young and middle-aged academic and technical backbone of Kunming Medical University 60117190423100 young and middle-aged academic and technical backbone of Kunming Medical University 60117190451Grants from Yunnan Natural Science Foundation of China 2017FE468(-151)Grants from Yunnan Natural Science Foundation of China 2017FE468(-200)
6 · The paper itself

Abstract

WWP2 is an E3 ubiquitin ligase and plays an important role in regulation of many cellular biological activities through ubiquitination and degradation of its substrates. Recently accumulating evidences indicate that WWP2 plays a crucial part in the pathogenesis in different types of tumors. In this report, the role of this gene especially in tumorigenesis was reviewed. WWP2 is dysregulated in various of tumors, and it promotes carcinogenesis mainly through PTEN/Akt signaling pathway. WWP2 also participates in anti-cancer agents' sensitivity, indicating WWP2 may be a novel target for cancer treatment. WWP2 is one promising novel oncogene.

Indexed as

CarcinogenesisHumansOncogenesUbiquitin-Protein LigasesUbiquitin-Protein LigasesWWP2 protein, humanAktCancerPathogenesisWWP2

Identifiers

PMID30415470
OpenAlexW2899650120

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.